Bristol Myers Squibb Clears Key Benchmark, Hitting 80-Plus RS Rating
Focus on stocks with an RS Rating of 80 or higher for your watchlist. Bristol Myers Squibb (BMY) now has an RS Rating of 83, indicating market leadership potential. Look for a proper buy point as the stock forms and breaks out of a chart pattern.